Loading…
for educational and safety purposes
LGD-4033 and Ostarine both come up in the same conversations; they overlap on Muscle Growth. LGD-4033: LGD-4033, also known as ligandrol or VK5211, is an investigational nonsteroidal selective androgen receptor modulator, a class of compounds abbreviated as SARM. Ostarine: Ostarine, known in drug development as enobosarm or MK-2866, is an investigational selective androgen receptor modulator (SARM).
LGD-4033, also known as ligandrol or VK5211, is an investigational nonsteroidal selective androgen receptor modulator, a class of compounds abbreviated as SARM. It binds the androgen receptor, the same target acted on by testosterone, but is designed to stimulate muscle and bone while having weaker effects on other tissues. First described by Ligand Pharmaceuticals and later developed by Viking Therapeutics, it has been studied for muscle wasting but is not approved for any medical use, and it is banned in sport and sold illicitly to bodybuilders.
Ostarine, known in drug development as enobosarm or MK-2866, is an investigational selective androgen receptor modulator (SARM). SARMs are compounds designed to stimulate the androgen receptor in a tissue-selective way, aiming to build muscle and bone like anabolic steroids but with fewer effects on organs such as the prostate. Ostarine has been studied mainly for the muscle wasting associated with cancer and related conditions, but it is not approved as a medicine anywhere; it is prohibited in sport and has been the subject of regulatory warnings over its sale in bodybuilding and supplement products.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
Selective tissue-preferential agonist
Agonist (tissue-selective)
Dose-dependent suppression of endogenous testosterone
Lowers HDL and SHBG dose-dependently
Suppresses
Lowers
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.